Form 4: Bluebird Bio CEO Andrew Obenshain Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Andrew Obenshain, CEO of bluebird bio, sold shares of common stock on January 6, 2025, to cover tax withholding obligations related to the vesting of Restricted Stock Units.
Summary
- On January 6, 2025, Andrew Obenshain, the President and CEO of bluebird bio, sold 140 shares of common stock at a price of $9.24 per share.
- The sale was executed to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
- Following the transaction, Obenshain directly owns 18,571 shares of bluebird bio common stock.
- The number of securities reported have been adjusted to reflect a 1-for-20 reverse stock split effected by the Issuer on December 12, 2024.
Sentiment
Score: 5
Explanation: The document reports a routine transaction (sale of shares for tax obligations) and has a neutral sentiment.
Industry Context
Sales of shares to cover tax obligations are a routine part of executive compensation and are not necessarily indicative of the company's financial health or future prospects.
Key Dates
| Date | Description |
|---|---|
| 2024-09-23 | Date of Power of Attorney execution. |
| 2024-12-12 | 1-for-20 reverse stock split effected by the Issuer. |
| 2025-01-06 | Date of stock sale transaction. |
| 2025-01-08 | Date of signature for the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.